NLRP3/Caspase-1 Regulate Macrophage Efferocytosis by Modulating ADAM17-Mediated MerTK Cleavage in Liver

Ge Guan1, Chaoqun Yu2,3, Longyu Miao3

  • 1Organ Transplantation Center, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.

PubMed

Insights

NLRP3/Caspase-1 signaling impairs macrophage efferocytosis in liver ischemia-reperfusion injury (LIRI). Inhibiting ADAM17 restores efferocytosis, reduces LIRI severity, and may offer therapeutic benefits.

Area of Science:

  • Immunology
  • Hepatology
  • Molecular Biology

Background:

  • Macrophage efferocytosis is vital for resolving inflammation in liver ischemia-reperfusion injury (LIRI).
  • The NLRP3/Caspase-1 inflammasome pathway's role in LIRI-associated efferocytosis requires elucidation.

Purpose of the Study:

  • To investigate the impact of NLRP3/Caspase-1 signaling on macrophage efferocytosis during LIRI.
  • To identify the molecular mechanisms linking NLRP3/Caspase-1 activation to efferocytosis dysfunction.
  • To explore potential therapeutic targets for LIRI.

Main Methods:

  • Utilized genetic knockout mouse models (Nlrp3, Caspase-1) and myeloid/hepatocyte-specific knockouts.
  • Assessed LIRI severity, macrophage efferocytosis, and NLRP3/Caspase-1 pathway activation.
  • Investigated ADAM17-mediated MerTK cleavage and its effect on efferocytosis.
  • Analyzed serum soluble MerTK (s-Mer) levels in patients.

Main Results:

  • NLRP3/Caspase-1 pathway is activated early in LIRI, exacerbating injury.
  • Genetic or myeloid-specific deletion of Nlrp3/Caspase-1 reduced LIRI severity.
  • NLRP3/Caspase-1 activation promotes ADAM17-mediated MerTK cleavage, impairing efferocytosis.
  • ADAM17 inhibition restored efferocytosis and alleviated LIRI.
  • Elevated s-Mer levels correlated with LIRI severity and Caspase-1 activation in patients.

Conclusions:

  • NLRP3/Caspase-1 signaling drives LIRI by inhibiting macrophage efferocytosis via ADAM17/MerTK axis.
  • Targeting ADAM17 presents a promising therapeutic strategy for LIRI.
  • Soluble MerTK serves as a potential clinical biomarker for LIRI severity.

Related Concept Videos

Cleavage and Blastulation01:33

Cleavage and Blastulation

After a large-single-celled zygote is produced via fertilization, the process of cleavage occurs while zygotes travel through the uterine tube. Cleavage is a mitotic cell division that does not result in growth. With each round of successive cell division, daughter cells get increasingly smaller.
50.1K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.8K
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
13.9K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
904
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
26.4K